JBIO

Jade Biosciences, Inc. Common Stock

Small CapHealthcareNASDAQ

Weak39th percentile vs Healthcare stocks

Updated: Oct 30, 2026, 2:17 AM

Open JBIO on TradingViewAffiliate link

JBIOBELOW 200-DAY

Jade Biosciences, Inc. Common Stock

$14.24

-21.9% vs 200-day

200-day level: $18.24
Streak below: 33 days
Sector: Healthcare
Market cap: Small Cap
Exchange: NASDAQ
Avg volume (90d): 929.0K

Price history is not tracked for this symbol · Oct 30, 2026

Position vs 200-day MA

-21.9% below 200-day MA

JBIO is 21.9% below its 200-day MA for 33 days, worse than most of Healthcare stocks, at the 39th percentile.

Price

$14.24

200-day MA

$18.24

Streak below

33 days

Avg volume (90d)

929.0K

Market cap

$928M

Participation around JBIO

Above 200-day MA

JBIO's trend and the participation around it are sending mixed signals.

Healthcare

36%

310 of 855 stocks

S&P 500

63%

316 of 498 stocks

This stock is currently below its 200-day average. The comparison shows how much support the move has around it.

Technical peers

Closest 200-day positions in Healthcare

TOVX

Theriva Biologics, Inc.

-21.9%

SRTS

Sensus Healthcare, Inc

-21.9%

CELU

Celularity Inc. Class A Common Stock

-22.0%

HROW

Harrow, Inc. Common Stock

-22.0%

AMS

American Shared Hospital Services

-22.1%

GNLX

Genelux Corporation Common Stock

-22.1%

Browse all Healthcare stocks →See the full distribution →

View All Movers